Jupiter Neurosciences, Inc. (JUNS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jupiter Neurosciences, Inc., a Delaware corporation and Emerging Growth Company, on August 28, 2026. The report covers corporate governance actions taken by the Board of Directors on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change to the company's Bylaws and does not contain financial performance data.
Material Changes
The Board of Directors approved an amendment to the Company's Amended and Restated Bylaws effective immediately. The amendment modifies the quorum requirement for stockholder meetings. Previously, the requirement was not specified in this text, but the new provision states that holders of one-third (1/3) of the voting power, present in person or by proxy, shall constitute a quorum.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the procedural amendment of corporate bylaws.
Key Facts for Investor Verification
- The quorum requirement for stockholder meetings is now set at one-third (1/3) of the voting power.
- The amendment was approved by the Board of Directors on August 28, 2026, and is effective immediately.
- The full text of the amendment is filed as Exhibit 3.1 to this report.
- The company is classified as an Emerging Growth Company.